Arnout Ploos van Amstel
Förmögenhet: 543 000 $ per 2026-07-31
Förmögenhet: 543 000 $ per 2026-07-31
Arnout Ploos van Amstel is the founder of Apaxcel Life Sciences GmbH, founded in 2019, serving as Consultant.
Mr. van Amstel was the founder of MoonLake Immunotherapeutics, founded in 2020, serving as Chief Operating Officer from 2020 to 2021.
Former jobs include President, Managing Director & Vice President at Novartis Corp.
from 2010 to 2019 and Independent Director at Zura Bio Ltd. from 2023 to 2025.
Education includes graduate studies at the University of Groningen.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A 0,11 % | 2025-05-21 | 100 000 ( 0,11 % ) | 543 000 $ | 2026-07-31 |
| Företag | Position | Start |
|---|
| Företag | Position | Slut |
|---|---|---|
| ZURA BIO LIMITED | Direktör/Styrelseledamot | 2025-12-11 |
| MOONLAKE IMMUNOTHERAPEUTICS | Grundare | 2021-12-13 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | President | 2019-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
University of Groningen
University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Zura Bio Ltd.
Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån